|
On Thursday, a Food and Drug Administration (FDA) advisory council recommended approval for an epilepsy drug that would be the first plant-derived cannabidiol medicine for prescription use in the US.
0 Comments
Roching Holdings (SWX: RO), a Swiss developer of pharmaceutical and therapeutic medicines used in oncology, has agreed to acquire Ignyta (NASDAQ: RXRX), a US developer of personalized-medicine therapies designed for autoimmune diseases.
Kindred Healthcare (NYSE: KND) will be acquired for $9.00 per share in cash by Humana (NYSE: HUM), TPG Capital, and Welsh, Carson, Anderson & Stowe (“WCAS”). The total consideration equates to approximately $4.1 billion.
UnitedHealth Group (NYSE: UNH) announced it will purchase the primary and urgent care unit of DaVita (NYSE: DVA) for $4.9 billion.
|
Archives
March 2019
Categories |
RSS Feed
|
|
|
Services involving securities are offered through M&A Securities Group, Inc.4151 N Mulberry Drive Suite 252, Kansas City, MO, 64116 (“MAS") . Services involving real estate brokerage are offered through Berkshire Hathaway HomeServices Ambassador Real Estate ("BHHS"). Skyline Advisors, MAS, and BHHS are separate entities.
COPYRIGHT 2025. Skyline Advisors, LLC. ALL RIGHTS RESERVED. |